Plain-English translation of NCT05364957 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing an intragastric balloon—a soft, fluid-filled device placed in the stomach to help reduce appetite and promote weight loss—combined with dietary changes and exercise. The study is for people who have both obesity and asthma that remains difficult to control even while taking inhaled corticosteroid medications. Researchers believe that the balloon treatment may help improve asthma symptoms by reducing weight.
Obesity and asthma often go together and make each other worse. People with both conditions tend to have more asthma attacks and respond poorly to standard asthma medications. Researchers need better treatment options for this group.
You likely qualify if…
You likely don't qualify if…
If you're in the treatment group, you would have a balloon placed in your stomach through a minimally invasive procedure, then combine this with guided diet and exercise changes over the study period. The control group would receive diet and exercise guidance alone without the balloon. Both groups would attend regular follow-up visits to monitor asthma control, weight, and overall health throughout the trial.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
France